Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
08:30am, Friday, 15'th Oct 2021
Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11:00 a.m. ET Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11
Sensus Healthcare Announces Presentations, Demonstrations and Exhibit Booth at the 2021 Fall Clinical Conference in Las Vegas
08:30am, Thursday, 07'th Oct 2021
Premier gathering expected to host more than 1,200 physicians with 500 virtual participants is the first in-person dermatology medical conference in 18 months
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q2 2021 Results - Earnings Call Transcript
10:31am, Sunday, 08'th Aug 2021
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q2 2021 Results - Earnings Call Transcript
Sensus Healthcare to Host Second Quarter 2021 Financial Results and Business Update Conference Call on August 5, 2021
08:00am, Thursday, 29'th Jul 2021
BOCA RATON, Fla, July 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and n
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
01:55am, Sunday, 09'th May 2021
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
Sensus Healthcare to Host First Quarter 2021 Financial Results and Business Update Conference Call on May 6, 2021
04:00pm, Thursday, 29'th Apr 2021
BOCA RATON, Fla. , April 29, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an
Sensus Healthcare: Likely Post-Pandemic Sales Recovery Can Boost Share Price
05:48pm, Monday, 26'th Apr 2021
Sensus Healthcare stock fell to lows of $1.9 during 2020, from highs of >$9 in mid-2019, owing to a pandemic-induced collapse in annual sales from $27.3m to $9.6m in FY20. The company has developed Su
Sensus Healthcare to Participate in Three Investment Conferences During the Month of March
04:15pm, Monday, 08'th Mar 2021
BOCA RATON, Fla, March 08, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effec
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
12:21pm, Sunday, 28'th Feb 2021
Sensus Healthcare, Inc. (SRTS) CEO Joe Sardano on Q4 2020 Results - Earnings Call Transcript
SRTS Stock Price Increased 37.8% After Hours: Why It Happened
09:14pm, Thursday, 25'th Feb 2021
The stock price of Sensus Healthcare Inc (NASDAQ: SRTS) increased by 37.8% after hours as it went from a previous close of $3.81 to $5.25. This is why it happened.
Sensus Healthcare Granted U.S. Patent for Three-Dimensional Beam Forming X-Ray Source
08:00am, Tuesday, 23'rd Feb 2021
Patent covers beam splitting and sculpting capabilities of radiation to treat all types of solid tumors with Sculptura™ and potentially other devices Patent covers beam splitting and sculpting capab
BOCA RATON, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti
Sensus Healthcare' (SRTS) CEO Joe Sardano on Q3 2020 Results - Earnings Call Transcript
12:41pm, Saturday, 07'th Nov 2020
Sensus Healthcare' (SRTS) CEO Joe Sardano on Q3 2020 Results - Earnings Call Transcript
Sensus Healthcare Reports Third Quarter 2020 Financial Results
04:02pm, Thursday, 05'th Nov 2020
Conference call begins at 4:30 p.m. Eastern time today Conference call begins at 4:30 p.m. Eastern time today
